- Home
- TLPH vs GRF Comparison
TLPH vs GRF Comparison
Compare TLPH & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLPH | GRF |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 39.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLPH | GRF |
|---|---|---|
| Price | $1.03 | $10.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 230.5K | 2.2K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $9.60 |
| 52 Week High | $1.57 | $11.85 |
Technical Indicators
Market Signals| Indicator | TLPH | GRF |
|---|---|---|
| Relative Strength Index (RSI) | 60.11 | 48.56 |
| Support Level | $1.01 | $9.96 |
| Resistance Level | $1.44 | $10.13 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 65.98 | 36.67 |
Price Performance
Historical ComparisonAbout TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock, giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.